Shanti Inorganics Limited is an upcoming issue, offered in a price band of ₹79 to ₹83 per share, in lots of 3200 shares. Every figure below is taken from the issue's own filings and exchange disclosures.
Issue details
Price band
₹79 – ₹83
Lot size
3200 shares
Minimum investment
₹2,65,600
Issue size
₹47.24 Cr
Fresh issue
₹41.5 Cr
Offer for sale
—
Opens
31 Aug 2026
Closes
2 Sept 2026
Listing date
7 Sept 2026
Registrar
Kfin Technologies Ltd.
Symbol
SHANTIINOR
One lot of 3200 shares at the upper band price of ₹83 is ₹2,65,600 — the smallest retail application this issue accepts.
Lead managers: Vivro Financial Services Pvt. Ltd.
Reported financials
As disclosed in the offer document. Figures in ₹ crore unless the filing states otherwise.
Shanti Inorganics — financials from the offer document
PAT
Assets
Expense
Revenue
Period Ended
₹5.12
₹52.69
₹38.20
₹45.06
2024
₹7.99
₹66.04
₹47.69
₹58.46
2025
₹10.22
₹97.04
₹59.11
₹72.93
2026
₹2.50
₹110.73
₹12.73
₹16.10
May 2026
Strengths disclosed in the offer document
The company exports its products to various geographies, demonstrating geographical diversification.
The company has long-standing relationships with a diverse customer base across multiple industries.
The company's manufacturing facilities are strategically located near key raw material suppliers.
The company holds several quality certifications, including ISO 9001:2015, NSF, Kosher, Halal, and HACCP.
The company's management team has significant experience in the inorganic chemical industry.
The company has demonstrated consistent business growth and financial performance.
The company is expanding its manufacturing capacity to meet increasing demand and enhance operational efficiency.
Risk factors disclosed in the offer document
The company derives a substantial portion of its revenue from the food and beverages, oil-field, and chemical industries, making it vulnerable to declines in these sectors.
The company's inability to acquire new customers or retain existing major customers could materially impact its business.
The company does not maintain long-term contractual arrangements with most customers, increasing the risk of losing key customers.
A substantial portion of revenue is derived from exports, exposing the company to risks associated with international markets.
A significant increase in raw material costs, not matched by product pricing, could adversely affect profit margins.
The company has not made long-term supply arrangements with suppliers, creating a risk of material adverse effects on operations and profitability.
Any disturbance, slowdown, or shutdown of the company's manufacturing facilities could adversely impact its business operations and financial conditions.
Alphave is NISM-certified, not a SEBI-registered research analyst. There is no rating, verdict or recommendation on this issue anywhere on this page.
What it will list at
Nobody knows, and GMP is not a forecast of it. It is an unofficial over-the-counter quote reported by third parties, shown here with its source time so you can judge how stale it is.
Your allotment
Allotment is decided by the registrar (Kfin Technologies Ltd.) after the issue closes. Track the whole calendar in the IPO Centre.
Every Indian IPO in one place — mainboard and SME — from the day dates are announced through subscription, listing and after. Each issue carries its price band, lot size, the minimum a retail applicant needs, subscription by QIB, NII and retail category, the reported grey market premium with the time it was recorded, and the registrar and lead managers handling it.
What you can do here
Open, upcoming, closed-awaiting-listing and listed issues, filterable
Price band, lot size and the minimum retail application for each issue
Subscription by QIB, NII and retail, as reported by the exchange
Reported grey market premium with its full recorded history and timestamps
Strengths and risk factors as disclosed in each offer document
Registrar, lead managers, issue size and the fresh-issue / offer-for-sale split
Related tools on Alphave
Every tool reads the same live feed and the same filed statements, so a name you find in one opens in any of the others.
Open to everyone; the per-issue terminal needs a free account. Alphave is NISM-certified, not a SEBI-registered research analyst — nothing here is investment advice or a recommendation to buy or sell any security.